Scientists map the magic mushroom brain
NCT ID NCT04501653
Summary
This study used detailed brain imaging to understand how psilocybin, the active compound in 'magic mushrooms,' affects brain connections. Eleven healthy adults received either psilocybin or a comparison drug (methylphenidate) during multiple MRI scan sessions. The goal was to create a precise map of brain changes to help explain how psilocybin might work as a future therapy for mental health conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSILOCYBIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.